{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:19:01Z","timestamp":1790777941250,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["IP\/SC- 15666"],"award-info":[{"award-number":["IP\/SC- 15666"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0224211","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T11:32:50Z","timestamp":1571830370000},"page":"e0224211","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0722-7577","authenticated-orcid":true,"given":"Cecilia","family":"Nakid-Cordero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Arzouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5217-2769","authenticated-orcid":true,"given":"Nicolas","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Choquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Burrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Autran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Vieillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Guihot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"pone.0224211.ref001","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00382-17","article-title":"Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases","volume":"91","author":"RJ Abbott","year":"2017","journal-title":"J Virol"},{"key":"pone.0224211.ref002","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/ajt.14603","article-title":"Comprehensive review of post\u2013organ transplant hematologic cancers","volume":"18","author":"VR Dharnidharka","year":"2018","journal-title":"Am J Transplant"},{"key":"pone.0224211.ref003","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ckj\/sfx122","article-title":"Risk factors associated with post-kidney transplant malignancies: An article from the Cancer-Kidney International Network","volume":"11","author":"B Sprangers","year":"2018","journal-title":"Clin Kidney J"},{"key":"pone.0224211.ref004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1702693","article-title":"Post-Transplantation Lymphoproliferative Disorders in Adults","volume":"378","author":"D Dierickx","year":"2018","journal-title":"N Engl J Med"},{"key":"pone.0224211.ref005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular Responses to Viral Infection in Humans: Lessons from Epstein-Barr Virus","volume":"25","author":"AD Hislop","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"pone.0224211.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.01658","article-title":"Epstein-Barr virus-specific immune control by innate lymphocytes","volume":"8","author":"C M\u00fcnz","year":"2017","journal-title":"Front Immunol"},{"key":"pone.0224211.ref007","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","article-title":"The immune response to primary EBV infection: A role for natural killer cells","volume":"129","author":"H Williams","year":"2005","journal-title":"Br J Haematol"},{"key":"pone.0224211.ref008","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/ndt\/gfv362","article-title":"Long-term CD4 lymphopenia is associated with accelerated decline of kidney allograft function","volume":"31","author":"Y Luque","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0224211.ref009","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1016\/j.transproceed.2009.09.033","article-title":"Long-Term Kinetics of a T-Lymphocytes Subset in Kidney Transplant Recipients: Relationship With Posttransplant Malignancies","volume":"41","author":"F Glowacki","year":"2009","journal-title":"Transplant Proc"},{"key":"pone.0224211.ref010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trim.2016.01.001","article-title":"High proportion of CD95+and CD38+in cultured CD8+T cells predicts acute rejection and infection, respectively, in kidney recipients","volume":"34","author":"E Mancebo","year":"2016","journal-title":"Transpl Immunol"},{"key":"pone.0224211.ref011","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1600-6143.2008.02279.x","article-title":"PD-1 expression and IL-2 loss of cytomegalovirus- specific t cells correlates with viremia and reversible functional anergy","volume":"8","author":"U Sester","year":"2008","journal-title":"Am J Transplant"},{"key":"pone.0224211.ref012","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/523652","article-title":"Programmed Death\u20131 Expression in Liver Transplant Recipients as a Prognostic Indicator of Cytomegalovirus Disease","volume":"197","author":"C La Rosa","year":"2008","journal-title":"J Infect Dis"},{"key":"pone.0224211.ref013","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.4049\/jimmunol.1001024","article-title":"EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function","volume":"186","author":"C Macedo","year":"2011","journal-title":"J Immunol"},{"key":"pone.0224211.ref014","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.trim.2005.02.001","article-title":"EBV-specific memory CD8+T cell phenotype and function in stable solid organ transplant patients","volume":"14","author":"C Macedo","year":"2005","journal-title":"Transpl Immunol"},{"key":"pone.0224211.ref015","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/petr.12156","article-title":"Increased levels of PD-1 expression on CD8 T cells in patients post-renal transplant irrespective of chronic high EBV viral load","volume":"17","author":"J Moran","year":"2013","journal-title":"Pediatr Transplant"},{"key":"pone.0224211.ref016","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/TP.0b013e318279968d","article-title":"EBV-specific T-Cell immunity in pediatric solid organ graft recipients with posttransplantation lymphoproliferative disease","volume":"95","author":"N Wilsdorf","year":"2013","journal-title":"Transplantation"},{"key":"pone.0224211.ref017","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.trim.2012.02.001","article-title":"Adequate control of primary EBV infection and subsequent reactivations after cardiac transplantation in an EBV seronegative patient","volume":"27","author":"FL Pietersma","year":"2012","journal-title":"Transpl Immunol"},{"key":"pone.0224211.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2013.00046","article-title":"The peripheral NK cell repertoire after kidney transplantation is modulated by different immunosuppressive drugs","volume":"4","author":"C Neudoerfl","year":"2013","journal-title":"Front Immunol"},{"key":"pone.0224211.ref019","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/eji.201141826","article-title":"CMV drives clonal expansion of NKG2C + NK cells expressing self-specific KIRs in chronic hepatitis patients","volume":"42","author":"V B\u00e9ziat","year":"2012","journal-title":"Eur J Immunol"},{"key":"pone.0224211.ref020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4049\/jimmunol.1301951","article-title":"Expansion of CMV-mediated NKG2C+ NK cells associates with the development of specific de novo malignancies in liver-transplanted patients","volume":"192","author":"A Achour","year":"2014","journal-title":"J Immunol"},{"key":"pone.0224211.ref021","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.healun.2014.09.038","article-title":"Natural killer cell deficiency in patients with non-Hodgkin lymphoma after lung transplantation","volume":"34","author":"F Baychelier","year":"2015","journal-title":"J Hear Lung Transplant"},{"key":"pone.0224211.ref022","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1097\/TP.0000000000000792","article-title":"Natural killer lymphocytes are dysfunctional in kidney transplant recipients on diagnosis of cancer","volume":"99","author":"MN Peraldi","year":"2015","journal-title":"Transplantation"},{"key":"pone.0224211.ref023","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/eji.201141832","article-title":"Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD","volume":"42","author":"S Wiesmayr","year":"2012","journal-title":"Eur J Immunol"},{"key":"pone.0224211.ref024","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1182\/blood-2003-03-0951","article-title":"Rituximab therapy for HIV-associated Castleman disease","volume":"102","author":"AG Marcelin","year":"2003","journal-title":"Blood"},{"key":"pone.0224211.ref025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Human Cytotoxic T Lymphocyte Responses To Epstein Barr Virus Infection","volume":"15","author":"AB Rickinson","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"pone.0224211.ref026","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1086\/491741","article-title":"Differential Targeting and Shifts in the Immunodominance of Epstein-Barr Virus\u2013Specific CD8 and CD4 T Cell Responses during Acute and Persistent Infection","volume":"192","author":"T Woodberry","year":"2005","journal-title":"J Infect Dis"},{"key":"pone.0224211.ref027","doi-asserted-by":"crossref","first-page":"8649","DOI":"10.1128\/JVI.75.18.8649-8659.2001","article-title":"Differential Immunogenicity of Epstein-Barr Virus Latent-Cycle Proteins for Human CD4 \u03e9 T-Helper 1 Responses","volume":"75","author":"ANN Leen","year":"2001","journal-title":"J Virol"},{"key":"pone.0224211.ref028","first-page":"1","article-title":"Pathogen-Specific T Cell Polyfunctionality Is a Correlate of T Cell Efficacy and Immune Protection","volume":"10","author":"A Boyd","year":"2015","journal-title":"PLoS One"},{"key":"pone.0224211.ref029","volume-title":"gplots: Various R Programming Tools for Plotting Data","author":"GR Warnes","year":"2016"},{"key":"pone.0224211.ref030","volume-title":"Agglomerative methods","author":"BS Everitt","year":"2011"},{"key":"pone.0224211.ref031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pathogens7010031","article-title":"The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency","volume":"7","author":"C Styles","year":"2018","journal-title":"Pathogens"},{"key":"pone.0224211.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2016.00457","article-title":"Role of EBNA-3 family proteins in EBV associated B-cell lymphomagenesis","volume":"7","author":"S Bhattacharjee","year":"2016","journal-title":"Front Microbiol"},{"key":"pone.0224211.ref033","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/intimm\/10.3.311","article-title":"CD8(hi+)CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity","volume":"10","author":"L Mollet","year":"1998","journal-title":"Int Immunol"},{"key":"pone.0224211.ref034","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1182\/blood-2010-03-274076","article-title":"Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders","volume":"116","author":"K Jones","year":"2010","journal-title":"Blood"},{"key":"pone.0224211.ref035","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1371\/journal.pmed.0040096","article-title":"HIV patients developing primary CNS lymphoma lack EBV-specific CD4 + T cell function irrespective of absolute CD4+ T cell counts","volume":"4","author":"O Gasser","year":"2007","journal-title":"PLoS Med"},{"key":"pone.0224211.ref036","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/ijc.23845","article-title":"Patients with Epstein Barr virus-positive lymphomas have decreased CD4 + T-cell responses to the viral nuclear antigen 1","volume":"123","author":"KN Heller","year":"2008","journal-title":"Int J Cancer"},{"key":"pone.0224211.ref037","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/imm.12106","article-title":"Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay","volume":"139","author":"SA Calarota","year":"2013","journal-title":"Immunology"},{"key":"pone.0224211.ref038","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/intimm\/dxh099","article-title":"Determining virological, serological and immunological parameters of EBV infection in the development of PTLD","volume":"16","author":"JE Davis","year":"2004","journal-title":"Int Immunol"},{"key":"pone.0224211.ref039","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/14760584.2017.1293529","article-title":"Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities","volume":"16","author":"V Dasari","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"pone.0224211.ref040","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/bmt.2016.17","article-title":"Virus-specific T-cell banks for \u201coff the shelf\u201d adoptive therapy of refractory infections","volume":"51","author":"RJ O\u2019Reilly","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"pone.0224211.ref041","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MOT.0000000000000210","article-title":"Immunosenescence in renal transplantation","volume":"20","author":"M Seyda","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"pone.0224211.ref042","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/TP.0b013e31825306ff","article-title":"Terminally differentiated CD8 + temra cells are associated with the risk for acute kidney allograft rejection","volume":"94","author":"MGH Betjes","year":"2012","journal-title":"Transplantation"},{"key":"pone.0224211.ref043","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.humimm.2018.06.006","article-title":"Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients","volume":"79","author":"JM Schaenman","year":"2018","journal-title":"Hum Immunol"},{"key":"pone.0224211.ref044","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2009.05966.x","article-title":"Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation","volume":"25","author":"Y Wang","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"pone.0224211.ref045","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1399-0012.2008.00815.x","article-title":"CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation","volume":"22","author":"E Boleslawski","year":"2008","journal-title":"Clin Transplant"},{"key":"pone.0224211.ref046","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1054\/bjoc.2001.1943","article-title":"Chronic immune activation and inflammation as the cause of malignancy","volume":"85","author":"KJ O\u2019Byrne","year":"2001","journal-title":"Br J Cancer"},{"key":"pone.0224211.ref047","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fimmu.2016.00126","article-title":"PD1-expressing T cell subsets modify the rejection risk in renal transplant patients","volume":"7","author":"R Pike","year":"2016","journal-title":"Front Immunol"},{"key":"pone.0224211.ref048","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fimmu.2017.01444","article-title":"Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs","volume":"8","author":"G Pittari","year":"2017","journal-title":"Front Immunol"},{"key":"pone.0224211.ref049","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/onc.2017.209","article-title":"Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers","volume":"36","author":"Y Liu","year":"2017","journal-title":"Oncogene"},{"key":"pone.0224211.ref050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2016.04.025","article-title":"Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization","volume":"139","author":"S Pesce","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"pone.0224211.ref051","doi-asserted-by":"crossref","first-page":"72961","DOI":"10.18632\/oncotarget.12150","article-title":"PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma","volume":"7","author":"A Beldi-Ferchiou","year":"2016","journal-title":"Oncotarget"},{"key":"pone.0224211.ref052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37218-x","article-title":"Transient increase of activated regulatory T cells early after kidney transplantation","volume":"9","author":"YS Mederacke","year":"2019","journal-title":"Sci Rep"},{"key":"pone.0224211.ref053","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1600-6143.2011.03566.x","article-title":"Mechanisms of Donor-Specific Tolerance in Recipients of Haploidentical Combined Bone Marrow\/Kidney Transplantation","volume":"11","author":"G Andreola","year":"2011","journal-title":"Am J Transplant"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0224211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:28:44Z","timestamp":1588969724000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0224211"}},"subtitle":[],"editor":[{"given":"James","family":"Drummond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0224211","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]}}}